OmerosvsUnitedHealth

OMER and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Omeros (OMER) has a market value of $1.0B and UnitedHealth (UNH) $300B. Over the last year, with dividends, OMER moved +64.8% and UNH +8.2%. The P/E is 10.3 for OMER and 18.9 for UNH. Dividend yield: OMER none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    OMER$1.0B

    UNH$300B

    UNH is 297 times OMER

  • Revenue, 12 months

    OMER–

    UNH$450B

  • Net income, 12 months

    OMER$98M

    UNH$15.9B

    UNH is 161 times OMER

  • Operating margin

    OMER–

    UNH5.3%

  • ROIC

    OMER–

    UNH11.3%

  • P/E

    OMER10.3

    UNH18.9

    UNH is 1.8 times OMER

  • Dividend yield

    OMER0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    OMER+80.5%

    UNH-19.5%

    100.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

OMER+80.5%

UNH-19.5%

010020020222023202420252026
Returns by period
PeriodOMERWith dividendsUNHWith dividends
1 year since November 18, 2025+64.8%Price +64.8%+8.2%Price +5.4%
3 years since November 17, 2023+754.3%+104.4% a yearPrice +754.3%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+80.5%+12.5% a yearPrice +80.5%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016+7.0%+0.7% a yearPrice +7.0%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

OMEROmerosUNHUnitedHealth

Valuation

OMERUNH
Valuation
Price$14.01$330.48
Market value$1.0B$300B
Enterprise value (EV)–$346B
P/E10.318.9
P/E, 5-year median–25.0
P/B–2.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

OMERUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months$98M$15.9B
Free cash flow, 12 months-$37M$22.8B
Earnings per share, 12 months$1.37$17.52
Revenue growth, year on year-34.0%11.8%
Revenue growth a year, past+15.4%over 4 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

OMERUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC–11.3%
ROE–15.5%

Balance sheet

OMERUNH
Balance sheet
Cash$95M$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover-4.3×6.2×

Dividends and buybacks

OMERUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: OMER or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Omeros or UnitedHealth?

By market value, UnitedHealth ($300B) is about 297.4 times Omeros ($1.0B), at today's prices.

How did OMER and UNH stock do over the last 10 years?

Since November 21, 2016, OMER's price moved +7.0% and UNH's +119.7%. With dividends: OMER +7.0% (+0.7% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, OMER or UNH?

The dividend yield at today's price is none for Omeros and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of OMER and UNH?

At today's price, the P/E is 10.3 for OMER and 18.9 for UNH. It is the share price over the last twelve months' earnings per share.

Which is the better investment, Omeros or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.